Skip to search formSkip to main contentSkip to account menu

Phenylbutazone 200 MG/ML Injectable Solution [Equi-Phar]

Known as: Equi-Phar 200 MG/ML Injectable Solution, PHENYLBUTAZONE 200 mg in 1 mL INTRAVENOUS INJECTION [EQUI-PHAR] 
National Institutes of Health

Related topics

Related topics

2 relations
Injectable SolutionPhenylbutazone

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2014
2014
Connaissances des médecins généralistes et des pharmaciens d’officine en matière de dopage sportif
Review
2008
Review
2008
Monitoring des Arzneimittelmissbrauchs bei Klienten ambulanter Suchtberatungsstellen (PHAR-MON, ehemals: ebis-med)
OBJECTIVES: The monitoring system PHAR-MON (formerly: ebis-med) documents the misuse of pharmaceuticals in addiction counseling… 
2005
2005
MILESTONES IN THE HISTORY OF EPILEPSY 1 Introduction Epilepsy
Introduction Epilepsy is a common medical and social disorder or group of disorders with unique characteristics. Epilepsy is… 
2003
2003
Application of real‐time data assembly (RTDA) to a pivotal phase III pediatric trial: A proactive approach to population pharmacokinetic/pharmacodynamic (PK/PD) dataset creation
2001
2001
Prophylaxis of venous thrombosis
Opinion statement|Mechanical measures such as graduated compression stockings and intermittent compression boots are available… 
1999
1999
Measuring Sensitivity in Pharmacoeconomic Studies
AbstractObjective: The aim of the present study is to describe a refinement of a previously presented method, based on the… 
1997
1997
Measuring Sensitivity in Pharmacoeconomic Studies
SummaryThe level of uncertainty with regard to the outcomes of pharmacoeconomic studies cannot be completely covered by the… 
1977
1977
Efficacy Testing of Valproic Acid Compared to Ethosuximide in Monkey Model: I. Dosage Regimen Design in the Presence of Diurnal Oscillations
Valproic acid (VPA) and ethosuximide (ESM) were administered by intravenous infusion at a constant rate to 12 chronically… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)